BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 18095749)

  • 1. Discovery and development of the epothilones : a novel class of antineoplastic drugs.
    Reichenbach H; Höfle G
    Drugs R D; 2008; 9(1):1-10. PubMed ID: 18095749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical discovery of ixabepilone, a highly active antineoplastic agent.
    Lee FY; Borzilleri R; Fairchild CR; Kamath A; Smykla R; Kramer R; Vite G
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):157-66. PubMed ID: 18347795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of ixabepilone, a novel epothilone analogue.
    Pivot X; Dufresne A; Villanueva C
    Clin Breast Cancer; 2007 Apr; 7(7):543-9. PubMed ID: 17509162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epothilones as Natural Compounds for Novel Anticancer Drugs Development.
    Villegas C; González-Chavarría I; Burgos V; Iturra-Beiza H; Ulrich H; Paz C
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biosynthetic gene cluster for the microtubule-stabilizing agents epothilones A and B from Sorangium cellulosum So ce90.
    Molnár I; Schupp T; Ono M; Zirkle R; Milnamow M; Nowak-Thompson B; Engel N; Toupet C; Stratmann A; Cyr DD; Gorlach J; Mayo JM; Hu A; Goff S; Schmid J; Ligon JM
    Chem Biol; 2000 Feb; 7(2):97-109. PubMed ID: 10662695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel tubulin-targeting agents: anticancer activity and pharmacologic profile of epothilones and related analogues.
    Fumoleau P; Coudert B; Isambert N; Ferrant E
    Ann Oncol; 2007 Jul; 18 Suppl 5():v9-15. PubMed ID: 17656562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New natural epothilones from Sorangium cellulosum, strains So ce90/B2 and So ce90/D13: isolation, structure elucidation, and SAR studies.
    Hardt IH; Steinmetz H; Gerth K; Sasse F; Reichenbach H; Höfle G
    J Nat Prod; 2001 Jul; 64(7):847-56. PubMed ID: 11473410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epothilones as lead structures for new anticancer drugs--pharmacology, fermentation, and structure-activity-relationships.
    Altmann KH; Memmert K
    Prog Drug Res; 2008; 66():273, 275-334. PubMed ID: 18416309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five new epothilone metabolites from Sorangium cellulosum strain So0157-2.
    Wang J; Zhang H; Ying L; Wang C; Jiang N; Zhou Y; Wang H; Bai H
    J Antibiot (Tokyo); 2009 Sep; 62(9):483-7. PubMed ID: 19575038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis & antitumor activity of epothilones B and D and their analogs.
    Cheng H; Huang G
    Future Med Chem; 2018 Jun; 10(12):1483-1496. PubMed ID: 29788770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A common pharmacophore for epothilone and taxanes: molecular basis for drug resistance conferred by tubulin mutations in human cancer cells.
    Giannakakou P; Gussio R; Nogales E; Downing KH; Zaharevitz D; Bollbuck B; Poy G; Sackett D; Nicolaou KC; Fojo T
    Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2904-9. PubMed ID: 10688884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in beta-tubulin map to domains involved in regulation of microtubule stability in epothilone-resistant cell lines.
    He L; Yang CP; Horwitz SB
    Mol Cancer Ther; 2001 Nov; 1(1):3-10. PubMed ID: 12467233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent developments in the chemical biology of epothilones.
    Altmann KH
    Curr Pharm Des; 2005; 11(13):1595-613. PubMed ID: 15892665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diversity of metabolites and their bio-activities in myxobacterium Sorangium cellulosum].
    Li Y; Hu W; Wu B; Yan Z; Chen Q
    Wei Sheng Wu Xue Bao; 2001 Dec; 41(6):716-22. PubMed ID: 12552829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epothilone B and its analogs - a new family of anticancer agents.
    Altmann KH
    Mini Rev Med Chem; 2003 Mar; 3(2):149-58. PubMed ID: 12570848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of multidrug resistance: the potential role of microtubule-stabilizing agents.
    Fojo T; Menefee M
    Ann Oncol; 2007 Jul; 18 Suppl 5():v3-8. PubMed ID: 17656560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical investigations with epothilones in breast cancer models.
    Burris HA
    Semin Oncol; 2008 Apr; 35(2 Suppl 2):S15-21; quiz S39. PubMed ID: 18410795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A myxobacterium strain Sorangium cellulosum AHB125 producing epothilone B and other anticancer substances.
    Guo WJ; Tao GJ; Tao WY; Cui FJ; Jin XC; Bi F; Xu ZH; Ao ZH
    Nat Prod Res; 2007 Dec; 21(14):1256-65. PubMed ID: 18075888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-cultivation of Sorangium cellulosum strains affects cellular growth and biosynthesis of secondary metabolite epothilones.
    Li PF; Li SG; Li ZF; Zhao L; Wang T; Pan HW; Liu H; Wu ZH; Li YZ
    FEMS Microbiol Ecol; 2013 Aug; 85(2):358-68. PubMed ID: 23551077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of epothilone B (patupilone) with microtubules as detected by two-dimensional solid-state NMR spectroscopy.
    Kumar A; Heise H; Blommers MJ; Krastel P; Schmitt E; Petersen F; Jeganathan S; Mandelkow EM; Carlomagno T; Griesinger C; Baldus M
    Angew Chem Int Ed Engl; 2010 Oct; 49(41):7504-7. PubMed ID: 20809556
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.